short banner

Pharmaceutical and Healthcare Management

The Pharmaceutical and Healthcare Management concentration in the EMBA program at the University of Charleston is an efficient and effective way for working individuals to advance their careers and broaden their education backgrounds in pharmaceutical and healthcare management. The curriculum combines theory and practical experience to give candidates insight into the intricacies of a constantly changing economic and healthcare business environment.

The course is divided into five 12-week modules. Participants meet every other weekend (Friday 5:30 – 9:00 p.m.; Saturday 8:00 a.m. – 5:00 p.m.) for 14 months. The first three modules are held at the Equities House in the center of Charleston’s downtown business district, together with students in the University of Charleston’s highly successful Executive Master of Business Administration program. The fourth and fifth modules, designed specifically for students in the Pharmaceutical and Healthcare Management concentration, are held in the School of Pharmacy at the University of Charleston’s main campus. Learn more about the EMBA-PHM program, including Tuition & Fees.

Should You Join the EMBA PHM program?

If you are looking for a first-rate, reasonably priced, exciting educational program that will allow you to keep your current job while vastly improving your professional credentials, this program is for you. The EMBA PHM concentration is intended for full-time business executives, middle managers, or those who aspire to become managers in a pharmaceutical or healthcare organization. The University of Charleston will provide you one of the best healthcare management education programs available anywhere, not only in West Virginia, but across the eastern United States.

Important Information for International Students

Under U.S. immigration regulations, international students are not eligible for this program because international students on F-1 student visas are not eligible to work full-time off campus during their studies in the U.S.